Abbott Laboratories

NYSE: ABT · Real-Time Price · USD
131.19
1.91 (1.48%)
At close: Aug 15, 2025, 10:14 AM

Abbott Laboratories Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
13.4B 5.72B 6.93B 7.07B
Depreciation & Amortization
3.22B 3.24B 3.27B 3.54B
Stock-Based Compensation
673M 644M 685M 640M
Other Working Capital
-8.82B -1.13B -458M -1.22B
Other Non-Cash Items
482M 126M 215M 55M
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
-9.22B -2.48B -1.52B -771M
Operating Cash Flow
8.56B 7.26B 9.58B 10.53B
Capital Expenditures
-2.21B -2.2B -1.78B -1.89B
Cash Acquisitions
1M -837M 48M -53M
Purchase of Investments
-169M -159M -185M -173M
Sales Maturities Of Investments
28M 43M 152M 77M
Other Investing Acitivies
9M 22M 22M 26M
Investing Cash Flow
-2.34B -3.13B -1.74B -2.01B
Debt Repayment
-537M -2.48B -699M -248M
Common Stock Repurchased
-1.29B -1.23B -3.79B -2.3B
Dividend Paid
-3.84B -3.56B -3.31B -3.2B
Other Financial Acitivies
264M 167M 167M 255M
Financial Cash Flow
-5.4B -7.09B -7.64B -5.49B
Net Cash Flow
720M -2.99B 83M 2.96B
Free Cash Flow
6.35B 5.06B 7.8B 8.65B